1. Agrotis, A. Condron, M., & Bobik, A. (2000). Alternative splicing within the TGF-beta type I receptor gene (ALK-5) generates two major functional isoforms in vascular smooth muscle cells. FEBS Letters, 467, 128–132.
2. Anbazhagan, R., Bornman, D. M., Johnston, J. C., Westra, W. H., & Gabrielson, E. (1999). The S387Y mutation of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma. Cancer Research, 59, 3363–3364.
3. Arkwright, P, D., Laurie, S., Super, M., Pravica, V., Schwarz, M. J., Webb, A. K., Hutchinson, I. V., (2000). TGF-beta(l) genotype and accelerated decline in lung function of patientswithcystic fibrosis. Thorax, 55, 459–462.
4. Ashley, D. M., Kong, F. M., Bigner, D. D., & Hale, L. P, (1998). Endogenous expression of transforming growth factor beta-1 inhibits growth and tumorigenicity and enhancesfas-mediated apoptosis in a murine high-grade glioma model. Cancer Research, 58, 302–309.
5. Bandyopadhyay, A., Zhu, Y., Cibull, M. L., Bao, L. W., Chen, C. G., & Sun, L. Z. (1999). A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Research, 59, 5041–5046.